Don E. Griswold

7.7k citations
120 papers · 6.4k · h-index 40

Impact in

Papers in

  • Immunology 49
    • Immune Response and Inflammation 17
    • Immune Cell Function and Interaction 12
  • Molecular Biology 30
    • Receptor Mechanisms and Signaling 8
Co-authors
Jerry L. Adams (14 shared papers)Edward F. Webb (25 shared papers)Bartholomew J. Votta (4 shared papers)John C. Lee (9 shared papers)David C. Underwood (5 shared papers)A M Badger (9 shared papers)Peter R. Young (5 shared papers)Jeremy N. Bradbeer (2 shared papers)
Journals
Journal of Pharmacology and Experimental Therapeutics (9 papers)Journal of Medicinal Chemistry (8 papers)Cellular Immunology (5 papers)The Journal of Immunology (5 papers)Inflammation Research (4 papers)
Partner nations
United StatesUnited KingdomCanada

In The Last Decade

Don E. Griswold

120 papers receiving 6.1k citations

Peers

Don E. Griswold
Comparison fields: 5 of 128
  • Immunology 2.0k
  • Immunology and Allergy 413
  • Physiology 1.2k
  • Oncology 1.2k
  • Pharmacology 628
Replace Andreas J. R. Habenicht with:
Andreas J. R. Habenicht Germany
Patricia Andrade‐Gordon United States
Klaus Resch Germany
Takehiko Yokomizo Japan
Franco Dallegri Italy
Henry J. Showell United States
Manfred Brockhaus Switzerland
Kazuo Umezawa Japan
A. W. Ford‐Hutchinson Canada
Stefan Zahler Germany
Don E. Griswold relative to Andreas J. R. Habenicht Germany Andreas J. R. Habenicht's profile →
Citations per field
00.5×1.6×
Andreas J. R. Habenicht · 1×
Citations per year

Countries citing papers authored by Don E. Griswold

Since Specialization
Citations

This map shows the geographic impact of Don E. Griswold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don E. Griswold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don E. Griswold more than expected).

Fields of papers citing papers by Don E. Griswold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don E. Griswold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don E. Griswold. The network helps show where Don E. Griswold may publish in the future.

Co-authors

The 25 scholars most cited alongside Don E. Griswold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Don E. Griswold Line = papers co-authored together Don E. Griswold links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.
Journal of Pharmacology and Experimental Therapeutics ·A M Badger, Jeremy N. Bradbeer, Bartholomew J. Votta, J C Lee, Jerry L. Adams, Don E. Griswold
1996453
2
Inhibition of p38 MAP kinase as a therapeutic strategy
Immunopharmacology ·John C. Lee, Sanjay Kumar, Don E. Griswold, David C. Underwood, Bartholomew J. Votta, Jerry L. Adams
2000386
3
Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration
Journal of Biological Chemistry ·John R. White, Judithann M. Lee, Peter R. Young, Robert Hertzberg, Anthony J. Jurewicz, Margery A. Chaikin, Katherine L. Widdowson, James J. Foley, Lenox D. Martin, Don E. Griswold, Henry M. Sarau
1998341
4
Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family
Journal of Biological Chemistry ·Sanjay Kumar, Peter McDonnell, Ruth Lehr, Lauren A. Tierney, Maritsa N. Tzimas, Don E. Griswold, Elizabeth A. Capper, Ruth Tal‐Singer, Grace I. Wells, Michael L. Doyle, Peter R. Young
2000281
5
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
American Journal of Physiology-Lung Cellular and Molecular Physiology ·David C. Underwood, Ruth R. Osborn, Steven Bochnowicz, Edward F. Webb, David J. Rieman, John C. Lee, Anne M. Romanic, Jerry L. Adams, Douglas W.P. Hay, Don E. Griswold
2000266
6
Inflammatory mediators of experimental colitis in rats
Gastroenterology ·D Rachmilewitz, P L Simon, Lester W. Schwartz, Don E. Griswold, Joseph D. Fondacaro, Martin A. Wasserman
1989231
7
SB 239063, a Potent p38 MAP Kinase Inhibitor, Reduces Inflammatory Cytokine Production, Airways Eosinophil Infiltration, and Persistence
Journal of Pharmacology and Experimental Therapeutics ·David C. Underwood, Ruth R. Osborn, Charles J. Kotzer, Jerry L. Adams, John C. Lee, Edward F. Webb, Donald C. Carpenter, Steven Bochnowicz, Heath C. Thomas, Douglas W.P. Hay, Don E. Griswold
2000216
8
Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): Rationale for selective inhibition and progress to date
Medicinal Research Reviews ·Don E. Griswold, Jerry L. Adams
1996209
9
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis
Arthritis & Rheumatism ·Alison M. Badger, Don E. Griswold, Rasesh Kapadia, Simon Blake, Barbara A. Swift, Sandy J. Hoffman, George B. Stroup, Edward F. Webb, David J. Rieman, Maxine Gowen, Jeffrey C. Boehm, Jerry L. Adams, John C. Lee
2000186
10
Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
Immunology ·Bailin Liang, Debra B. Gardner, Don E. Griswold, Peter J. Bugelski, Xiao Yu R. Song
2006164
11
Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling
Cytokine ·Gaoyun Yang, A. Paige Davis Volk, Ted Petley, Eva Emmell, Jill Giles‐Komar, Xiaozhou Shang, Li J, Anuk Das, Dave Shealy, Don E. Griswold, Lily Li
2004160
12
Long-term activation of TLR3 by Poly(I:C) induces inflammation and impairs lung function in mice
Respiratory Research ·Nicole Stowell, Jonathan Seideman, Holly Raymond, Karen A Smalley, Roberta J. Lamb, Devon Egenolf, Peter J. Bugelski, Lynne A. Murray, P Marsters, Rachel Bunting, Richard A. Flavell, Lena Alexopoulou, Lani R. San Mateo, Don E. Griswold, Robert T. Sarisky, Moustapha Mbow, Anuk Das
2009149
13
Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models
Journal of Pharmacology and Experimental Therapeutics ·Jeffrey R. Jackson, Brian Bolognese, Leonard M. Hillegass, Shouki Kassis, Jerry L. Adams, Don E. Griswold, James D. Winkler
1998147
14
ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic
Pulmonary Pharmacology & Therapeutics ·Theodore J. Torphy, Mary S. Barnette, David C. Underwood, Don E. Griswold, S. Brøgger Christensen, R.D. Murdoch, Richard Nieman, C.H. Compton
1999134
15
Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis Inhibitors
Annals of the New York Academy of Sciences ·J. C. Lee, A M Badger, Don E. Griswold, Damien J. Dunnington, Alemseged Truneh, Bartholomew J. Votta, John R. White, Peter R. Young, Paul E. Bender
1993125
16
2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis
Bioorganic & Medicinal Chemistry Letters ·Timothy F. Gallagher, Susan M. Fier-Thompson, Ravi S. Garigipati, Margaret E. Sorenson, Juanita M. Smietana, Dennis Lee, Paul E. Bender, John C. Lee, Jeffrey T. Laydon, Don E. Griswold, Marie Chabot‐Fletcher, John Breton, Jerry L. Adams
1995119
17
Expression of ST2, an Interleukin-1 Receptor Homologue, Is Induced by Proinflammatory Stimuli
Biochemical and Biophysical Research Communications ·Sanjay Kumar, Maritsa N. Tzimas, Don E. Griswold, Peter R. Young
1997112
18
Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity
Bioorganic & Medicinal Chemistry Letters ·Jerry L. Adams, Jeffrey C. Boehm, Timothy F. Gallagher, Shouki Kassis, Edward F. Webb, Ralph Hall, Margaret E. Sorenson, Ravi S. Garigipati, Don E. Griswold, John C. Lee
200189
19
Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes
Bioorganic & Medicinal Chemistry Letters ·Jerry L. Adams, Jeffrey C. Boehm, Shouki Kassis, Peter D. Gorycki, Edward F. Webb, Ralph Hall, Margaret E. Sorenson, John C. Lee, Andrew D. Ayrton, Don E. Griswold, Timothy F. Gallagher
199888
20
Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice
Arthritis Research & Therapy ·David J. Shealy, Paul H. Wooley, Eva Emmell, Amy Volk, Amy S. Rosenberg, George Treacy, Carrie Wagner, Lois Mayton, Don E. Griswold, Xiaoyu Song
200287

About Don E. Griswold

Don E. Griswold is a scholar working on Immunology, Molecular Biology, Oncology, Pharmacology and Physiology, having authored 120 papers that have together received 6.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (20 papers), Immune Response and Inflammation (17 papers), Inflammatory mediators and NSAID effects (17 papers), Cytokine Signaling Pathways and Interactions (16 papers), Synthesis and biological activity (14 papers), Immune Cell Function and Interaction (12 papers), Receptor Mechanisms and Signaling (8 papers) and Neuropeptides and Animal Physiology (8 papers). The work is most often cited by research in Immunology (2.0k citations), Immunology and Allergy (413 citations), Physiology (1.2k citations), Oncology (1.2k citations) and Pharmacology (628 citations). Don E. Griswold has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jerry L. Adams, Edward F. Webb, Bartholomew J. Votta, John C. Lee, David C. Underwood, A M Badger, Peter R. Young, Jeremy N. Bradbeer, Nabil Hanna and Douglas W.P. Hay. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, Cellular Immunology, The Journal of Immunology and Inflammation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas J. R. HabenichtBreakdown of academic impact, for papers by Patricia Andrade‐GordonBreakdown of academic impact, for papers by Klaus ReschBreakdown of academic impact, for papers by Takehiko YokomizoBreakdown of academic impact, for papers by Franco DallegriBreakdown of academic impact, for papers by Henry J. ShowellBreakdown of academic impact, for papers by Manfred BrockhausBreakdown of academic impact, for papers by Kazuo UmezawaBreakdown of academic impact, for papers by A. W. Ford‐HutchinsonBreakdown of academic impact, for papers by Stefan Zahler